Sickle cell disease in Nigeria

Nigeria’s sickle cell disease evidence includes national burden models and research using genotypes measured in a household survey. Screening initiatives and support services add a distinct national context. Sickle cell trait, disease at birth and people living with the disease must be counted separately. [1] [2] [3]

Medically reviewed

Dr. Fitsum Admasu Tinsae

General Medicine, Public Health, Digital Health

Medical review applies to the clinical background reproduced from our sickle cell disease guide.

Page review recorded: 16 Oct 2026Reviewer profile →

Clinical background

SCD is inherited and present from birth. A person's genotype is the inherited combination of hemoglobin variants: HbSS is commonly called sickle cell anemia, while HbSC disease and sickle beta-thalassemia are other forms. Sickle cell trait is different. It is a carrier state with one sickle hemoglobin gene and usually does not produce the clinical syndrome of SCD. [1] [2]

Read the full sickle cell disease guide

Sickle cell disease data in Nigeria

Births with sickle-cell disease

179,000 affected live births

Nigeria, 2021

Population: Live births; both sexes

Age: Newborns

Sex: All sexes

Denominator: Not applicable — absolute count

Uncertainty: 95% UI 138,000–224,000

Method: GBD 2021 model: birth incidence, all-age prevalence, cause-specific mortality and total mortality among people with sickle-cell disease

Source [1]

People living with sickle-cell disease

2,590,000 people

Nigeria, 2021

Population: All ages; both sexes

Age: All ages

Sex: All sexes

Denominator: Not applicable — absolute count

Uncertainty: 95% UI 2,090,000–3,220,000

Method: GBD 2021 model: birth incidence, all-age prevalence, cause-specific mortality and total mortality among people with sickle-cell disease

Source [1]

Sickle-cell disease birth incidence

2,290 per 100,000 live births

Nigeria, 2021

Population: Live births; both sexes

Age: Newborns

Sex: All sexes

Denominator: Live births

Uncertainty: 95% UI 1,760–2,870

Method: GBD 2021 model: birth incidence, all-age prevalence, cause-specific mortality and total mortality among people with sickle-cell disease

Source [1]

Model-estimated birth prevalence of HbSS

1.21 % of live births

Nigeria, 2018

Population: Birth prevalence inferred from 11,186 tested children aged 6–59 months in 7,411 households

Age: At birth (modelled)

Sex: Both sexes

Denominator: Modelled live births; inferred from allele frequencies in the 2018 child survey

Uncertainty: 95% CI: 1.09–1.37

Method: Hardy–Weinberg assumption near birth applied to nationally sampled 2018 NDHS genotypes

Interpretation: Model-estimated birth prevalence, not observed newborn-screening prevalence; do not equate with all-age GBD prevalence or infer a time trend.

Source [2]

Model-estimated birth prevalence of HbSC

0.24 % of live births

Nigeria, 2018

Population: Birth prevalence inferred from 11,186 tested children aged 6–59 months in 7,411 households

Age: At birth (modelled)

Sex: Both sexes

Denominator: Modelled live births; inferred from allele frequencies in the 2018 child survey

Uncertainty: 95% CI: 0.19–0.31

Method: Hardy–Weinberg assumption near birth applied to nationally sampled 2018 NDHS genotypes

Interpretation: Model-estimated birth prevalence, not observed newborn-screening prevalence; do not equate with all-age GBD prevalence or infer a time trend.

Source [2]

Sickle cell disease burden in Nigeria

The GBD 2021 study estimates 2,590,000 people living with sickle cell disease and 179,000 affected live births in Nigeria in 2021. The corresponding birth incidence is 2,290 per 100,000 live births. These source-rounded estimates include uncertainty intervals and are not registry totals. [1]

Genotype research and national estimates

A separate analysis of the 2018 Nigeria Demographic and Health Survey used test results from 11,186 children aged 6–59 months in 7,411 households. It estimated birth prevalence of 1.21% for HbSS and 0.24% for HbSC, using an assumption about genetic frequencies near birth. These are inferred birth estimates, not direct measurements in newborns. [2]

The GBD and NDHS-based analyses differ in model, genotype scope, reference period and denominator. Their estimates are kept in separate groups and do not show a time trend. A carrier or trait estimate must not be presented as the number of people with sickle cell disease. [1] [2]

Screening and national policy

In June 2026 the federal government described newborn screening implementation in selected primary and secondary facilities in Lagos, Kano and the Federal Capital Territory, with CHAI support. It also described integration of sickle cell services into primary healthcare and Nigeria-PEN. This documents the stated programme scope, rather than universal screening coverage. [3]

The health ministry lists a second edition of its national sickle cell disease guideline. The link below leads to the official publication catalogue; treatment decisions remain part of individual clinical care. [4]

Support and service information

Sickle Cell Foundation Nigeria describes newborn-screening support for primary and secondary facilities and genetic counselling at its National Sickle Cell Centre and associated clinics or clubs. Its programme page states that counselling requires prior appointments. The provider’s own page is the source for current arrangements. [5]

Organizations and official resources

Common questions

Frequently asked questions

Sources

  1. GBD 2021 sickle-cell disease — original appendix, Tables S9 and S13 — GBD 2021 Sickle Cell Disease Collaborators
  2. Child mortality from sickle cell disease in Nigeria: a model-estimated, population-level analysis of data from the 2018 DHS — Nnodu et al., The Lancet Haematology
  3. FG reaffirms commitment to closing sickle cell survival gap — Federal Ministry of Information and National Orientation, reporting FMoHSW
  4. Public Health Policies: national sickle cell and hypertension guidelines — Federal Ministry of Health and Social Welfare
  5. Our Programmes — Sickle Cell Foundation Nigeria